Published in Arthritis Res Ther on January 01, 2006
The mosaic of "seronegative" antiphospholipid syndrome. J Immunol Res (2014) 0.87
Single-step autoantibody profiling in antiphospholipid syndrome using a multi-line dot assay. Arthritis Res Ther (2011) 0.82
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol (2012) 0.81
"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome. J Immunol Res (2015) 0.78
Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies". J Immunol Res (2015) 0.77
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances. Nat Rev Rheumatol (2017) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods (1991) 16.64
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet (1990) 6.54
India ink staining of proteins on nitrocellulose paper. Anal Biochem (1983) 5.78
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A (1990) 4.59
The anticardiolipin syndrome. J Rheumatol (1986) 3.36
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet (1990) 2.87
Death, autoantigen modifications, and tolerance. Arthritis Res (2000) 1.75
Cardiolipin and apoptosis. Biochim Biophys Acta (2002) 1.70
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65
Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum (1998) 1.63
The anticardiolipin syndrome. Clin Exp Rheumatol (1986) 1.53
The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci U S A (1997) 1.51
Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol (1992) 1.47
Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ (2004) 1.42
Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death. Cell Death Differ (2003) 1.27
Cardiolipin: biosynthesis, remodeling and trafficking in the heart and mammalian cells (Review). Int J Mol Med (1998) 1.22
Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem (1998) 1.19
Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. Biochem J (1990) 1.16
Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol (1988) 1.15
Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity. Mol Cell Biol (2001) 1.13
Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin Exp Immunol (2000) 1.11
Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum (2000) 1.05
Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost (1995) 1.04
Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. J Rheumatol (1988) 1.03
Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol (1997) 1.02
Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid syndrome. Clin Diagn Lab Immunol (2000) 1.02
Lipids, cardiolipin and apoptosis: a greasy licence to kill. Cell Death Differ (2002) 0.94
Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL. Arterioscler Thromb Vasc Biol (1998) 0.94
Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemost (1996) 0.92
How do antiphospholipid antibodies bind beta2-glycoprotein I? Arthritis Rheum (2003) 0.92
Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells. Arterioscler Thromb Vasc Biol (2000) 0.91
Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res Ther (2005) 0.90
Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates. J Immunol Methods (1994) 0.89
Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol (2000) 0.88
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol (2005) 0.88
Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies. Thromb Haemost (1996) 0.87
Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein. Circulation (2001) 0.87
Protein S antibodies in acquired protein S deficiencies. Blood (1994) 0.85
Fatty acid chain is a critical epitope for antiphospholipid antibody. J Clin Immunol (1990) 0.84
Intrinsic fluorescence study of the interaction of human apolipoprotein H with phospholipid vesicles. Biochemistry (1999) 0.83
Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibody syndrome. Thromb Haemost (1998) 0.81
Implications of modifying cardiolipin acyl composition by diet. 1. Cardiolipin acyl chain is an important determinant in the binding to antiphospholipid antibodies in SLE sera. J Autoimmun (1992) 0.79
Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds. J Clin Immunol (1990) 0.76
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis (2010) 10.03
Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med (2009) 2.19
Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther (2006) 1.78
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome. Blood (2010) 1.67
Bcl-2 proteins and mitochondria--specificity in membrane targeting for death. Biochim Biophys Acta (2010) 1.66
Inflammation as "common soil" of the multifactorial diseases. Autoimmun Rev (2010) 1.57
Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome. Arthritis Rheumatol (2014) 1.53
Endosomal compartment contributes to the propagation of CD95/Fas-mediated signals in type II cells. Biochem J (2008) 1.53
An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev (2011) 1.44
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum (2009) 1.41
Echinococcus granulosus antigen B impairs human dendritic cell differentiation and polarizes immature dendritic cell maturation towards a Th2 cell response. Infect Immun (2007) 1.37
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol (2007) 1.34
Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria. FEBS Lett (2009) 1.19
Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum (2007) 1.18
Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement. Arthritis Res Ther (2004) 1.18
Strong intra- and inter-continental differentiation revealed by Y chromosome SNPs M269, U106 and U152. Forensic Sci Int Genet (2010) 1.17
Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol (2004) 1.17
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood (2003) 1.16
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum (2011) 1.15
CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol (2008) 1.13
Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling. Immunol Rev (2010) 1.12
Prion protein is a component of the multimolecular signaling complex involved in T cell activation. FEBS Lett (2004) 1.12
Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther (2004) 1.10
Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases. Immunol Lett (2012) 1.09
Fas stimulation of T lymphocytes promotes rapid intercellular exchange of death signals via membrane nanotubes. Cell Res (2009) 1.07
Death receptor signals to mitochondria. Cancer Biol Ther (2004) 1.07
Frequency of antibodies to mutated citrullinated vimentin in chronic obstructive pulmonary disease: comment on the article by Demoruelle et al. Arthritis Rheum (2013) 1.06
Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis. FASEB J (2010) 1.06
Clinical and ultrasonographic monitoring of response to adalimumab treatment in rheumatoid arthritis. J Rheumatol (2007) 1.04
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology (Oxford) (2011) 1.04
Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response. Blood (2005) 1.04
Autoimmune aspects of cytokine and anticytokine therapies. Am J Med (2003) 1.03
Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum (2012) 1.03
Does seronegative antiphospholipid syndrome really exist? Autoimmun Rev (2011) 1.03
Ultrasound elastography assessment of skin involvement in systemic sclerosis: lights and shadows. J Rheumatol (2010) 1.03
Synovial tissue heterogeneity and peripheral blood biomarkers. Curr Rheumatol Rep (2011) 1.02
Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome. Ann Rheum Dis (2012) 1.02
Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy. Autoimmun Rev (2013) 1.02
TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin. Arthritis Rheum (2011) 1.02
Dynamics of lipid raft components during lymphocyte apoptosis: the paradigmatic role of GD3. Apoptosis (2007) 1.02
The clearance of apoptotic cells: implications for autoimmunity. Autoimmun Rev (2002) 1.01
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. J Rheumatol (2008) 1.00
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy. Clin Exp Rheumatol (2011) 0.99
T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy. FASEB J (2012) 0.99
TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development. Immunogenetics (2013) 0.99
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis. Rheumatology (Oxford) (2011) 0.99
Advanced glycation end products of human β₂ glycoprotein I modulate the maturation and function of DCs. Blood (2011) 0.99
Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum (2007) 0.98
Vaccination and autoimmune rheumatic diseases. Autoimmun Rev (2008) 0.98
Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis (2012) 0.98
Neuroendocrine immunology of fibromyalgia. Ann N Y Acad Sci (2010) 0.98
Acyl coenzyme A thioesterase Them5/Acot15 is involved in cardiolipin remodeling and fatty liver development. Mol Cell Biol (2012) 0.97
Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period. Ann Rheum Dis (2007) 0.95
The 6-joint ultrasonographic assessment: a valid, sensitive-to-change and feasible method for evaluating joint inflammation in RA. Rheumatology (Oxford) (2011) 0.95
Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab. Arthritis Rheum (2005) 0.95
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin Res Cardiol (2012) 0.95
Occupational therapy in ankylosing spondylitis: Short-term prospective study in patients treated with anti-TNF-alpha drugs. Joint Bone Spine (2007) 0.94
Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) (2013) 0.94
Effect of tumor necrosis factor alpha antagonists in a patient with rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine (2007) 0.94
Apoptosis-induced changes in mitochondrial lipids. Biochim Biophys Acta (2010) 0.93
Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage. PLoS One (2012) 0.92
Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis. J Rheumatol (2005) 0.92
Association of GM3 with Zap-70 induced by T cell activation in plasma membrane microdomains: GM3 as a marker of microdomains in human lymphocytes. J Biol Chem (2002) 0.92
Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther (2004) 0.92
The interobserver reliability of ultrasound in knee osteoarthritis. Rheumatology (Oxford) (2012) 0.92
Infliximab treatment for ocular and extraocular manifestations of Behçet's disease. Jpn J Ophthalmol (2007) 0.92
Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonography. Clin Rheumatol (2007) 0.92
Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease. Arthritis Res Ther (2006) 0.91
Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles. PLoS One (2009) 0.91